Analysis shows that serological diagnostics improve accuracy of allergy therapies in determining venom allergy, indicating potential replacements for skin tests.
Background A reliable diagnosis of hymenoptera venom allergy is based on medical history, skin tests, and serological immunoglobulin E (IgE) determination. Over the past 10 years, component-resolved diagnostics (CRD) have gained in importance, and new strategies for interpreting serological double sensitization have been introduced with the bee/vespula venom-specific IgE ratio. Objectives The aim was to examine whether the bee/vespula venom-specific IgE ratio supplemented by CRD can be a reliable alternative to skin testing. Methods In a student project, the guideline algorithm for serological diagnostics was supplemented with the sIgE ratio (≥ 5:1) and tested in a simulation using anonymized data from a retrospective study (Fischer et al.). A partial data set of 375 cases with complete CRD and documented prick and intradermal test results was selected for the simulation. The performance of the algorithm was evaluated by a post hoc comparison of the algorithmic therapy recommendations with the allergen immunotherapies (AIT) actually implemented in the clinic. Results The simulation yielded 48.5% monosensitizations and 49.9% double sensitizations. In 56.3% of the double sensitizations, the ratio ≥ 5:1 indicated a dominant sensitization, which was classified as a mono-allergy. The therapies suggested by the algorithm corresponded to the clinically implemented AIT in 91% of cases; overall, the correspondence was 89.7%. While the algorithm predicted double AIT in 10% of cases, this was only clinically implemented in 2.7% of cases, with anamnestic details on sting circumstances and diagnostic certainty influencing the decision. Conclusion Standardized serological diagnostics with bee/vespula venom-specific IgE ratio and CRD provide high diagnostic precision and comprehensively demonstrate the progress made over the last 10 years. Skin tests remain a medically useful and valuable part of diagnostics, especially in cases of double sensitization.
No takes yet. Share an insight, caveat, or question.
Sebastian Volc (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: